1
|
Lee TH and Kang TH: DNA oxidation and
excision repair pathways. Int J Mol Sci. 20:60922019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Li C, Hu Z, Liu Z, Wang LE, Strom SS,
Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, et al:
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of
cutaneous melanoma: A case-control analysis. Cancer Epidemiol
Biomarkers Prev. 15:2526–2532. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lehmann AR: The xeroderma pigmentosum
group D (XPD) gene: One gene, two functions, three diseases. Genes
Dev. 15:15–23. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tsao H: Update on familial cancer
syndromes and the skin. J Am Acad Dermatol. 42:939–969. 2000.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Sobti RC, Berhane N, Melese D, Mahdi SA,
Gupta L, Thakur H and Singh N: Impact of XPD gene polymorphism on
risk of prostate cancer on North Indian population. Mol Cell
Biochem. 362:263–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Schabath MB, Delclos GL, Grossman HB, Wang
Y, Lerner SP, Chamberlain RM, Spitz MR and Wu X: Polymorphisms in
XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol
Biomarkers Prev. 14:878–884. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lovatt T, Alldersea J, Lear JT, Hoban PR,
Ramachandran S, Fryer AA, Smith AG and Strange RC: Polymorphism in
the nuclear excision repair gene ERCC2/XPD: Association between an
exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell
carcinoma. Hum Mutat. 25:353–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yin J, Li J, Ma Y, Guo L, Wang H and Vogel
U: The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C)
and risk of lung cancer in a Chinese population. Cancer Lett.
223:219–226. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
"xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/NOT_FOUND" id="d7e616" name="d7e616" shape="rect">PubMed/NCBI
|
10
|
Armstrong BK, Kricker A and English DR:
Sun exposure and skin cancer. Australas J Dermatol. 38 (Suppl
1):S1–S6. 1997. View Article : Google Scholar : PubMed/NCBI
|
11
|
Swetter SM, Johnson TM, Miller DR, Layton
CJ, Brooks KR and Geller AC: Melanoma in middle aged older men: A
multi-institutional survey study of factors related to tumor
thickness. Arch Dermatol. 145:397–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Afaq F, Adhami VM and Mukhtar H:
Photochemoprevention of ultraviolet B signaling and
photocarcinogenesis. Mutat Res. 571:153–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Alisha A, Perween N, Saijo M, Ghaskadbi SS
and Ghaskadbi S: Analysis of the conserved NER helicases (XPB and
XPD) and UV-induced DNA damage in Hydra. Biochim Biophys Acta Gen
Subj. 1862:2031–2042. 2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wood RD, Mitchell M and Lindahl T: Human
DNA repair genes, 2005. Mutat Res. 577:275–283. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kuptsova-Clarkson N, Ambrosone CB, Weiss
J, Baer MR, Sucheston LE, Zirpoli G, Kopecky KJ, Ford L, Blanco J,
Wetzler M and Moysich KB: XPD DNA nucleotide excision repair gene
polymorphisms associated with DNA repair deficiency predict better
treatment outcomes in secondary acute myeloid leukemia. Int J Mol
Epidemiol Genet. 1:278–294. 2010.PubMed/NCBI
|
16
|
Wang HY, Xiong GF, Zhang JX, Xu H, Guo WH,
Xu JJ and Xiong XY: The role of XPD in cell apoptosis and viability
and its relationship with p53 and cdk2 in hepatoma cells. Med
Oncol. 29:161–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yilmaz E, Celik O, Celik E, Turkcuoglu I,
Simsek Y, Karaer A, Otlu B, Gulbay G and Yesilada E: XPD and XRCC1
gene polymorphism in patients with normal and abnormal cervical
cytology by pap smear. Eur Rev Med Pharmacol Sci. 16:1713–1718.
2012.PubMed/NCBI
|
18
|
Szkandera J, Absenger G, Liegl-Atzwanger
B, Pichler M, Stotz M, Gerger S, Zacherl M, Renner W, Haijun M,
Leithner A and Gerger A: Common gene variants in RAD51, XRCC2 and
XPD are not associated with clinical outcome in soft-tissue sarcoma
patients. Cancer Epidemiol. 37:1003–1009. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Constantinescu-Aruxandei D,
Petrovic-Stojanovska B, Penedo JC, White MF and Naismith JH:
Mechanism of DNA loading by the DNA repair helicase XPD. Nucleic
Acids Res. 44:2806–2815. 2016. View Article : Google Scholar : PubMed/NCBI
|
20
|
Shkarupa VM, Mishcheniuk OY,
Henyk-Berezovska SO, Palamarchuk VO and Klymenko SV: Polymorphism
of DNA repair gene XPD Lys751Gln and chromosome aberrations in
lymphocytes of thyroid cancer patients exposed to ionizing
radiation due to the chornobyl accident. Exp Oncol. 38:257–260.
2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Santovito A, Delsoglio M, Manitta E, Picco
G, Meschiati G, Chiarizio M, Gendusa C and Cervella P: Association
of GSTT1 null, XPD 751 CC and XPC 939 CC genotypes with increased
levels of genomic damage among hospital pathologists. Biomarkers.
22:557–565. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
de Carvalho Lima EN, Piqueira JRC and
Maria DA: Advances in carbon nanotubes for malignant melanoma: A
chance for treatment. Mol Diagn Ther. 22:703–715. 2018. View Article : Google Scholar
|
23
|
Pfeifer GP and Besaratinia A: UV
wavelength-dependent DNA damage and human non-melanoma and melanoma
skin cancer. Photochem Photobiol Sci. 11:90–97. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Goode EL, Ulrich CM and Potter JD:
Polymorphisms in DNA repair genes and associations with cancer
risk. Cancer Epidemiol Biomarkers Prev. 11:1513–1530.
2002.PubMed/NCBI
|
25
|
Kertat K, Rosdahl I, Sun XF, Synnerstad I
and Zhang H: The Gln/Gln genotype of XPD codon 751 as a genetic
marker for melanoma risk and Lys/Gln as an important predictor for
melanoma progression: A case control study in the Swedish
population. Oncol Rep. 20:179–183. 2008.PubMed/NCBI
|